China Electrocardiograph (ECG) Market Size and Share
China Electrocardiograph (ECG) Market Analysis by Mordor Intelligence
The China Electrocardiograph Market size is expected to increase from USD 133.51 million in 2026 to USD 141.24 million in 2027 and reach USD 187.14 million by 2032, growing at a CAGR of 5.79% over 2027-2032.
An electrocardiograph (ECG or EKG) is a medical device used to record the heart's electrical activity. China’s ECG market is gaining traction as healthcare providers place greater emphasis on timely cardiovascular diagnosis and monitoring. The demand for ECG devices is being reinforced by the growing incidence of cardiac disorders, improved access to medical care, and the integration of advanced diagnostic solutions into clinical practice. As healthcare services continue to modernize and preventive care receives greater attention, the adoption of ECG systems is likely to increase steadily throughout the forecast period.
The increasing burden of cardiovascular diseases (CVDs) in China has become a key factor supporting demand for electrocardiography (ECG) devices, as healthcare providers prioritize timely cardiac assessment and continuous patient monitoring. Contributing factors such as population aging, changing lifestyle patterns, and rapid urbanization have heightened the incidence of heart-related conditions, reinforcing the need for effective diagnostic solutions. For example, statistics released by the National Health Commission’s Coronary Heart Disease Intervention Technology Quality Control Center in 2023 showed that reported ST-elevation myocardial infarction (STEMI) cases increased from 163,451 in 2022 to 177,598 in 2023. This rise in acute cardiac events highlights the growing clinical burden of cardiovascular disorders and is contributing to greater adoption of ECG-based diagnostic and monitoring technologies, supporting market expansion across China.
Innovations in ECG technology have significantly enhanced accessibility for healthcare providers and patients, making these tools easier to use. These advancements in devices, which offer improved accuracy, connectivity, and user-friendliness, are directly influencing the market dynamics. For instance, in December 2024, researchers at the University of Science and Technology of China achieved progress in non-contact cardiac activity perception. They utilized the "beat frequency effect," a critical physical phenomenon, to analyze the harmonics of cardiac mechanical activity. Such technological breakthroughs, emphasizing non-contact convenience and high precision, are increasing the adoption of ECG monitoring devices, thereby driving market growth.
The increasing prevalence of cardiac problems, coupled with advancements in ECG device technology, is anticipated to drive market growth over the forecast period. However, the limited availability of trained healthcare personnel capable of accurately interpreting ECG results and operating advanced cardiac diagnostic systems may hinder broader adoption. This challenge is particularly evident in lower-tier healthcare facilities, where resource and expertise gaps can restrict the effective utilization of ECG technologies.
Note: Market numbers in this report are based on Mordor Intelligence's proprietary estimation framework, which combines nine months of actuals with Q4 projections for base year 2026.
Market Trends and Insights
Holter ECG Systems Segment is Expected to Have Significant Growth in the Market Over the Forecast Period
China’s electrocardiograph (ECG) market is experiencing strong momentum in the Holter ECG systems segment, fueled by the growing need for long-term cardiac rhythm assessment and early detection of heart-related abnormalities. The segment’s expansion is being supported by continuous technological improvements in ambulatory monitoring devices, wider adoption of remote and outpatient cardiac diagnostics, and increasing awareness of cardiovascular health among both patients and healthcare providers. As a result, Holter ECG systems are becoming an increasingly important component of China’s cardiac diagnostic landscape, strengthening their contribution to the overall ECG market.
Holter monitors, which record ECG data continuously for 24 to 48 hours or longer, play a critical role in the cardiac monitoring market by enabling the detection of intermittent arrhythmias and other cardiac issues that standard ECGs might miss. This extended monitoring capability is essential for diagnosing sporadic conditions that are not evident during brief examinations. For example, data from THOTH (Suzhou) Medical in 2024 indicates that hospital outpatient clinics predominantly rely on the 24-hour dynamic electrocardiogram, commonly known as Holter, as a non-invasive solution for arrhythmia detection. In comparison, traditional ECGs, which capture a patient's signal for only 10 seconds, face limitations in addressing such diagnostic needs, further emphasizing the growing demand for Holter monitors in the market.
Furthermore, the COVID-19 pandemic in China significantly accelerated the adoption of telemedicine, driving the demand for remote monitoring solutions. This trend has directly impacted the market for Holter monitors, as these devices are highly compatible with telehealth applications. They allow physicians to remotely analyze patient readings and provide timely interventions, enhancing the efficiency of healthcare delivery. Consequently, the increasing reliance on continuous cardiac monitoring through Holter monitors, combined with the expanding telemedicine market, is expected to drive the growth of this segment in the country over the study period.
ECG Management Software is Expected to Have Fastest Growth in the Market Over the Forecast Period
ECG management software, a specialized application, enables healthcare providers to record, manage, analyze, and store electrocardiogram (ECG) data efficiently. The growing market for ECG management software in China is closely tied to the increasing adoption of digital health technologies, which streamline healthcare operations and improve patient outcomes. Additionally, the rising demand for efficient electronic health record (EHR) management and the ongoing expansion of healthcare services are driving market growth. Furthermore, innovations in artificial intelligence (AI), machine learning (ML), and cloud-based solutions are enhancing the functionality of ECG management software, making it a critical tool across various healthcare settings and further accelerating its adoption.
ECG management software plays a crucial role in population health initiatives by enabling the monitoring of at-risk patients and the proactive management of chronic conditions, such as those requiring percutaneous coronary intervention (PCI) for heart disease. The growing adoption of this software aligns with the increasing demand for efficient healthcare solutions in the market. For instance, the National Health Commission reported that mainland China registered 1.63 million coronary intervention cases in 2023. This figure was derived from two primary sources: online direct reporting, which accounted for 865,126 cases, and supplementary data verified by provincial quality control centers, totaling 770,929 cases. The PCI segment demonstrated significant market growth, with a robust increase of 26.44% in 2023 compared to 2022. Provinces such as Hebei, Beijing, Henan, Shandong, and Zhejiang led in case numbers, reflecting regional trends that could influence market dynamics and demand for ECG management solutions.
The increasing frequency of coronary interventions, which require continuous monitoring supported by historical data, is significantly driving the demand for ECG software. This growing reliance on ECG software to manage cardiac activities is directly contributing to the expansion of this market segment over the forecast period.
Competitive Landscape
Market Concentration
China’s electrocardiograph (ECG) market features a competitive environment shaped by both well-established manufacturers and a growing number of innovative entrants. While a handful of leading companies maintain significant market positions, ongoing product development, technological innovation, and expanding healthcare demand continue to create opportunities for new participants. The presence of vendors offering niche and application-specific ECG solutions further enhances market diversity, fostering an active and continuously evolving competitive landscape. Some of the major players in the market include EDAN Instruments, Inc., Nihon Kohden Corporation, Koninklijke Philips N.V., SCHILLER, Lepu Medical Technology(Beijing)Co.,Ltd., among others.
China Electrocardiograph (ECG) Industry Leaders
-
Lepu Medical Technology(Beijing)Co.,Ltd.
-
EDAN Instruments, Inc
-
Nihon Kohden Corporation
-
Koninklijke Philips N.V.
-
SCHILLER
- *Disclaimer: Major Players sorted in no particular order
China Electrocardiograph (ECG) Market Companies Covered in this Report
- Lepu Medical
- Contec Medical Systems
- EDAN Instruments, Inc.
- Nihon Kohden
- Koninklijke Philips
- Schiller
- Shanghai MedEco Industry Co.,Ltd.
- Jiangsu Rooe Medical Technology Co.,Ltd.
Recent Industry Developments in China Electrocardiograph (ECG) Market
- July 2024: Beijing Winnie Huili Medical Equipment Co., Ltd, a marketing agent for Welch Allyn, Inc., has received approval from the National Medical Products Administration (NMPA) for its Electrocardiograph (ECG) device, registered under Certificate Number 20142075933. This approval highlights the company's role in expanding the availability of advanced ECG devices in the medical equipment market.
- May 2024: Shenzhen Kaiwoer Electronics Co., Ltd has received approval from the National Medical Products Administration (NMPA) for its Multi-channel ECG machine, registered under Certificate Number 20213070059. This approval positions the company to strengthen its presence in the medical devices market, particularly in the diagnostic equipment segment.
China Electrocardiograph (ECG) Market Report Scope
As per the scope of the report, an electrocardiograph (ECG) is a medical device used to record the heart's electrical activity. The device captures the heart's electrical signals and produces a graphical representation known as an electrocardiogram.
The China ECG market report provides a comprehensive analysis of the current state and growth potential of the ECG market in the country. The China electrocardiograph (ECG) market is segmented by product type, which includes resting (12-lead ECG) systems, stress ECG systems, Holter ECG systems, and ECG management software. The report offers the market size in terms of both value (in USD) and volume (in units) for the above segments.
Segmentation Overview
| Resting ECG Systems |
| Stress ECG Systems |
| Holter ECG Systems |
| ECG Management Software |
| By Product Type | Resting ECG Systems |
| Stress ECG Systems | |
| Holter ECG Systems | |
| ECG Management Software |
Key Questions Answered in the Report
How big is the China Electrocardiograph Market?
The China Electrocardiograph Market size is expected to reach USD 133.51 million in 2026 and grow at a CAGR of 5.79% to reach USD 187.14 million by 2032.
What is the current China Electrocardiograph Market size?
In 2026, the China Electrocardiograph Market size is expected to reach USD 133.51 million.
Who are the key players in China Electrocardiograph Market?
Lepu Medical Technology(Beijing)Co.,Ltd., EDAN Instruments, Inc, Nihon Kohden Corporation, Koninklijke Philips N.V. and SCHILLER are the major companies operating in the China Electrocardiograph Market.
What years does this China Electrocardiograph Market cover, and what was the market size in 2025?
In 2025, the China Electrocardiograph Market size was estimated at USD 126.20 million. The report covers the China Electrocardiograph Market historical market size for years: 2021, 2022, 2023, 2024, and 2025. The report also forecasts the China Electrocardiograph Market size for years: 2026, 2027, 2028, 2029, 2030, 2031, and 2032.